My Tysabri Diary...
I just had an interesting telephone conversation with a Team Leader of Biogen/MSActiveSource with regard to Tysabri infusions being scheduled prior to the 28 day interval (every four weeks-the 'recommended' dosage time between infusions per the Tysabri label, see page 3 under Full Prescribing Information http://tinyurl.com/37psjy) and he told me [paraphrasing] that if the prescribing physician recommends a prescribing interval of 21 days (every three weeks) for the MS patient, this is not a violation of the Touch program, and only needs to be cleared with the 'payor' a.k.a. the insurance company (this might be a big obstacle to overcome).
You can bet your bottom dollar I am going to be contacting my neurologist first thing Monday morning to discuss this with her as usually going into the third week after my infusion, I can feel that Tysabri's benefits have worn off. You can disagree with me all you want, but unless you feel the same way I do, you cannot understand.
If there are other MS patients that are on Tysabri therapy, and they are in the same boat as me (Tysabri wearing off after three weeks), I would strongly suggest that you contact your neurologist and advised them of the above. I am not sure how Kaiser Permanente will react to this news, or how other payors will react, but I'm definitely going to call my neurologist first thing Monday morning and discuss this with her.
I also mentioned in my conversation with him how very disappointing it is to see that Biogen is not even promoting Tysabri's superior efficacy (67%) over Avonex (32%); that MS patients are being kept in the dark regarding the above; Biogen doesn't even have a Tysabri patient story on their website for other MS patients to see; not even anything about Tysabri never having been linked to PML when used as a monotherapy in a MS patient with a strong immune system.
Nothing at all regarding these issues on the Biogen website. All Biogen is doing is promoting an inferior MS medication (Avonex), and promoting Rituxin which has been linked to 24 cases of PML, including two deaths. It's rather disgusting if you ask me.
Good luck to all MS patients!
((((hugs))))
Love, Lauren :)
I just had an interesting telephone conversation with a Team Leader of Biogen/MSActiveSource with regard to Tysabri infusions being scheduled prior to the 28 day interval (every four weeks-the 'recommended' dosage time between infusions per the Tysabri label, see page 3 under Full Prescribing Information http://tinyurl.com/37psjy) and he told me [paraphrasing] that if the prescribing physician recommends a prescribing interval of 21 days (every three weeks) for the MS patient, this is not a violation of the Touch program, and only needs to be cleared with the 'payor' a.k.a. the insurance company (this might be a big obstacle to overcome).
You can bet your bottom dollar I am going to be contacting my neurologist first thing Monday morning to discuss this with her as usually going into the third week after my infusion, I can feel that Tysabri's benefits have worn off. You can disagree with me all you want, but unless you feel the same way I do, you cannot understand.
If there are other MS patients that are on Tysabri therapy, and they are in the same boat as me (Tysabri wearing off after three weeks), I would strongly suggest that you contact your neurologist and advised them of the above. I am not sure how Kaiser Permanente will react to this news, or how other payors will react, but I'm definitely going to call my neurologist first thing Monday morning and discuss this with her.
I also mentioned in my conversation with him how very disappointing it is to see that Biogen is not even promoting Tysabri's superior efficacy (67%) over Avonex (32%); that MS patients are being kept in the dark regarding the above; Biogen doesn't even have a Tysabri patient story on their website for other MS patients to see; not even anything about Tysabri never having been linked to PML when used as a monotherapy in a MS patient with a strong immune system.
Nothing at all regarding these issues on the Biogen website. All Biogen is doing is promoting an inferior MS medication (Avonex), and promoting Rituxin which has been linked to 24 cases of PML, including two deaths. It's rather disgusting if you ask me.
Good luck to all MS patients!
((((hugs))))
Love, Lauren :)